SCHEMBL7423871

SCHEMBL7423871

CC(=O)CON1CCc2ccc([N+](=O)[O-])cc2C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ ACHE P22303 1/20 0.40
▸ HTR1A P08908 3/20 0.39
▸ DRD1 P21728 3/20 0.39
▸ DRD2 P14416 3/20 0.39
▸ HTR2A P28223 3/20 0.39
▸ RECQL P46063 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ CASP4 P49662 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ CASP9 P55211 1/20 0.38
▸ CASP6 P55212 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ SIRT2 Q8IXJ6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420931 0.89 ACHE (0.39) ACHEHTR1ADRD1DRD2HTR2A
SCHEMBL7418416 0.81 KDM4E (0.39) DRD2MAPTCASP1CASP7ALDH1A1
SCHEMBL7419302 0.75 DPP7 (0.42) L3MBTL1POLBTDP1DRD2GAA
SCHEMBL15727806 0.74 HTR1A (0.50) ACHEHTR1ADRD1DRD2HTR2A
SCHEMBL7307524 0.73 KMT2A (0.44) L3MBTL1ACHEDRD2MAPTALDH1A1
SCHEMBL31537993 0.71 HTR1A (0.44) TDP1ACHEHTR1ADRD1DRD2
SCHEMBL2310023 0.66 ALDH1A1 (0.55) ALDH1A1SIRT2
SCHEMBL16559365 0.66 MAPT (0.61) TDP1ACHEGAAMAPTCASP1
SCHEMBL5298639 0.66 CASP1 (0.53) TDP1ACHEHTR1ADRD1MAPT
SCHEMBL981641 0.65 NOTUM (0.60) DRD2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5602145-A Bicyclic fibrinogen antagonists SMITHKLINE BEECHAM CORPORATION (US) 1997-02-11 — — US disclosed
EP-0702671-A4 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 1996-06-19 — — EP disclosed
EP-0702671-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1996-03-27 — — EP disclosed
WO-1994029273-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-12-22 — — WO disclosed
Send feedback